July 22, 2026
HeroSupport SA is proud to announce that NYU Grossman School of Medicine is the first clinical site to participate in the SHIELD clinical study, with Prof. Naamit Gerber as Principal Investigator.
Dr. Gerber is a professor and vice chair of education in the Department of Radiation Oncology at NYU Grossman School of Medicine, as well as the co-director of the breast cancer and hematologic malignancies disease management groups at NYU Langone’s Perlmutter Cancer Center.
Click here to read more : Press release